Ignite Creation Date:
2025-12-24 @ 10:02 PM
Ignite Modification Date:
2025-12-28 @ 12:30 AM
Study NCT ID:
NCT06554535
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-08-15
First Post:
2024-08-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of Serplulimab With Chemotherapy and Aspirin in Untreated Extensive-Stage Small Cell Lung Cancer
Sponsor:
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
AB20240810
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None